| Dr Linnea Estes Terranova, PSYD | |
|
950 Circle Dr, Salinas, CA 93905-2150 | |
| (831) 757-6237 | |
| (831) 757-8458 |
| Full Name | Dr Linnea Estes Terranova |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 17 Years |
| Location | 950 Circle Dr, Salinas, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366696635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY22287 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspring Psychological Services Inc | 2961763784 | 11 |
News Archive
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
Their battle with cancer is not the only thing that unites the Labrada sisters of Houston who are now cancer-free and strong advocates for women taking charge of their bodies.
Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient's health, drugs and instruments used, team communication, and the wisdom of the surgeon's hand. To advance safety and innovation in today's operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.
An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.
› Verified 1 days ago
| Entity Name | Wellspring Psychological Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336680495 PECOS PAC ID: 2961763784 Enrollment ID: O20180219000988 |
News Archive
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
Their battle with cancer is not the only thing that unites the Labrada sisters of Houston who are now cancer-free and strong advocates for women taking charge of their bodies.
Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient's health, drugs and instruments used, team communication, and the wisdom of the surgeon's hand. To advance safety and innovation in today's operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.
An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Linnea Estes Terranova, PSYD 175 Ford Rd, Carmel Valley, CA 93924-9621 Ph: (831) 659-1259 | Dr Linnea Estes Terranova, PSYD 950 Circle Dr, Salinas, CA 93905-2150 Ph: (831) 757-6237 |
News Archive
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
Their battle with cancer is not the only thing that unites the Labrada sisters of Houston who are now cancer-free and strong advocates for women taking charge of their bodies.
Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient's health, drugs and instruments used, team communication, and the wisdom of the surgeon's hand. To advance safety and innovation in today's operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.
An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.
› Verified 1 days ago
Dr. Brian Millard Lippincott, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1270 Natividad Rd, Room 200, Salinas, CA 93906 Phone: 831-784-2105 | |
Dr. Lynn Deutsch, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1270 Natividad Rd, Salinas, CA 93906 Phone: 831-755-4510 | |
Dr. Mauro Malacon Amador, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 32 E Alisal St, Suite 212, Salinas, CA 93901 Phone: 831-754-2551 | |
Dr. Walda Kung Singleton, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1270 Natividad, Salinas, CA 93906 Phone: 831-755-8155 | |
Dr. Edward F. Macias, ED.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 950 Circle Dr, Salinas, CA 93905 Phone: 831-757-6237 Fax: 831-757-8458 | |
Sarah Jean Radel, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 610 Baldwin Street, Salinas, CA 93907 Phone: 888-512-2695 | |
Eimee Villanueva, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Main St Ste 210b, Salinas, CA 93901 Phone: 831-796-1525 |